Kaupinen Wes - President and CEO, Director, 10%+ Owner at PALVELLA THERAPEUTICS, INC.

Issuer-level insider activity

Role
President and CEO, Director, 10%+ Owner
Issuer ticker
PVLA on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kaupinen Wes since 13 Sep 2025

Reported holdings for Kaupinen Wes in PALVELLA THERAPEUTICS, INC.

Form 4 holding President and CEO, Director, 10%+ Owner

PIERIS PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
243,831
Estimated value
Report date
05 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director, 10%+ Owner

PALVELLA THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
124,603
Estimated value
Report date
05 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Kaupinen Wes in PALVELLA THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .